Back to Vet Dispatch

Canine

Trazodone for Dogs: Situational Anxiety and Post-Op Confinement Dosing

Jul 11, 2026 6 min read

Bottom line

Trazodone is a serotonin antagonist/reuptake inhibitor (SARI) that has become a first-reach agent for canine situational anxiety and, especially, for making post-operative cage rest tolerable. All canine use is off-label; there is no veterinary-labeled product [1]. Reach for it when you need a relatively fast, single-event anxiolytic (onset roughly 1–2 hours) or an adjunct to layer onto a daily SSRI/TCA for breakthrough anxiety. Common dosing sits around 2–7.5 mg/kg PO q8–24h, titrated to effect, not to exceed ~19.5 mg/kg in any 24-hour period [1]. The dominant safety concern is serotonin syndrome when combined with other serotonergic drugs (fluoxetine, TCAs, tramadol, MAOIs including selegiline and amitraz) [2].

From reading to clinical reasoning

Pressure-test the decisions behind this article

Open Clinical Desk with the public topic prefilled. Add patient context only after you are inside the secure vet workspace.

trazodone dogs dose anxiety

Patient details stay inside the authenticated workspace.

Drug facts

  • Class: Serotonin antagonist and reuptake inhibitor (SARI); an atypical antidepressant/anxiolytic [3].
  • Mechanism: At the low-to-moderate doses used clinically, trazodone antagonizes postsynaptic 5-HT2A receptors and inhibits serotonin reuptake, with additional H1-histaminergic and alpha-1-adrenergic antagonism that drives the sedation and mild hypotensive effect [3]. At high doses the serotonergic agonism predominates, which is the mechanistic basis for serotonin syndrome [2].
  • Regulatory status: Off-label / extralabel in all species — no products are labeled for veterinary use; prescribing relies on repurposed human formulations [2].
  • Formulations: Human immediate-release tablets (commonly 50, 100, 150, 300 mg), plus extended-release products; immediate-release is the workhorse for both situational and post-op use [2].

Indications

  • Situational / event anxiety: Discrete, predictable stressors — veterinary visits, travel, thunderstorms, and fireworks — where a single pre-event dose is the goal. Trazodone's onset is fast enough for same-day use, unlike SSRIs that need weeks to reach effect.
  • Post-operative confinement and hospitalization stress: The best-supported niche. In an open-label trial of dogs recovering from orthopedic surgery, 89% (32/36) of owners rated their dog moderately or extremely improved in confinement tolerance and calmness over the recovery period, and the drug was well tolerated alongside NSAIDs, antimicrobials, and other post-op medications [4]. This makes trazodone a practical tool for enforcing strict cage rest.
  • Adjunct to a daily anxiolytic: Layered onto an SSRI or TCA for breakthrough or situational anxiety. The original case series that put trazodone on the map was exactly this use — an adjunctive agent in dogs with anxiety disorders, well tolerated over a wide dose range and enhancing behavioral calming on daily or as-needed dosing [5].

Dosing

Doses below are off-label and should be titrated to the individual patient. Start low and work up.

  • General range (Merck): 2–7.5 mg/kg PO q8–24h as needed, not exceeding ~19.5 mg/kg in any 24-hour period [1].
  • Situational / single-event use: Give one dose ahead of the anticipated stressor; timing 1–2 hours before the event aligns with the onset window [3]. Many clinicians trial the dose on a low-stress day first to confirm tolerability and gauge sedation before relying on it for the real event.
  • Ongoing / post-op confinement: The published orthopedic-recovery protocol started at ~3.5 mg/kg PO q12h beginning the day after surgery, increased after ~3 days to ~7 mg/kg PO q12h, with the option to escalate to ~7–10 mg/kg PO q8h if needed [4]. The original adjunctive case series similarly reported tolerability across a wide dose range on daily or as-needed dosing [5]; the practical takeaway from both is to titrate to effect rather than commit to a fixed dose.

Onset & what to tell the owner

Onset is relatively rapid: in the post-surgical trial, owner-reported median onset was 31–45 minutes with a median duration of effect of ≥ 4 hours [4]; clinically, effect is generally seen within about 1–2 hours of an oral dose [3]. Counsel owners to: dose ahead of the trigger rather than after anxiety has already peaked; expect sedation and possible wobbliness; do a trial dose before a high-stakes event; and contact you if they see agitation or restlessness rather than calming (paradoxical excitation), which warrants re-evaluation.

Adverse effects

Generally well tolerated [4]. Watch for:

  • Sedation, lethargy, and ataxia — the most common, dose-related effects [2].
  • GI upset (vomiting, diarrhea) and appetite changes [2].
  • Panting and hypotension, more likely at higher doses [2].
  • Paradoxical excitation — agitation, restlessness, or increased fearfulness instead of calming [2]. Discontinue or reassess rather than pushing the dose.

Drug interactions & contraindications

The headline risk is serotonin syndrome when trazodone is combined with other serotonergic agents: SSRIs (e.g., fluoxetine), TCAs (e.g., clomipramine, amitriptyline), tramadol, metoclopramide, and MAOIs including selegiline and the amitraz found in some collars/dips [2]. Because trazodone is so often used as an adjunct to a daily SSRI or TCA, this combination is common by design — use it deliberately, start at the low end, and monitor for signs (GI upset, tremor/hyperesthesia, agitation, mydriasis, hyperthermia, seizures) [2]. Concurrent MAOI use is a contraindication [3]. Hepatic metabolism means caution in hepatic disease; the alpha-1 and H1 antagonism warrants caution in patients with cardiac disease or hypotension. Note the look-alike/sound-alike confusion between trazodone and tramadol on prescriptions — a real dispensing hazard given both are serotonergic [3].

Frequently Asked Questions

What is the trazodone dose for a dog? The commonly cited range is 2–7.5 mg/kg PO every 8–24 hours as needed, not exceeding roughly 19.5 mg/kg in any 24-hour period, titrated to effect. All canine use is off-label. For situational anxiety, a single dose is given about 1–2 hours before the stressor; for post-operative confinement, published protocols start near 3.5 mg/kg q12h and escalate to ~7 mg/kg q12h.

Is trazodone approved for use in dogs? No. There is no veterinary-labeled trazodone product. All canine use is off-label (extralabel), relying on repurposed human immediate-release tablets. This should be reflected in your informed-consent conversation with the owner.

How fast does trazodone work in dogs? Relatively quickly. Clinical effect is generally seen within about 1–2 hours of an oral dose, and in the post-surgical trial the owner-reported median onset was 31–45 minutes with a median duration of at least 4 hours. This fast onset is why trazodone is useful for single-event anxiety, unlike SSRIs that take weeks.

Can trazodone be combined with fluoxetine or another SSRI? Yes, and it commonly is — trazodone is frequently used as an adjunct to a daily SSRI or TCA for breakthrough anxiety. The trade-off is serotonin syndrome risk, so combine deliberately: start at the low end, use the lowest effective dose, and monitor for GI upset, tremor, agitation, mydriasis, hyperthermia, or seizures.

When is trazodone contraindicated or used with caution? Concurrent MAOI use (including selegiline and amitraz) is a contraindication. Use caution when stacking on other serotonergics such as tramadol or TCAs, in hepatic disease given hepatic metabolism, and in cardiac disease or pre-existing hypotension given the alpha-1 and H1 antagonism.

What are the most common side effects of trazodone in dogs? Sedation, lethargy, and ataxia are most common and dose-related, followed by GI upset, panting, and hypotension at higher doses. Paradoxical excitation — agitation or restlessness instead of calming — warrants reassessment rather than a dose increase, and priapism is a rare but reported effect in intact males.

Is trazodone effective for post-operative cage rest? This is its best-supported use. In an open-label trial of dogs recovering from orthopedic surgery, 89% of owners rated their dog moderately or extremely improved in confinement tolerance and calmness, and the drug was well tolerated alongside NSAIDs and antimicrobials. It is a practical tool for enforcing strict post-op confinement.

References

  1. Merck Veterinary Manual — Common Drugs Used to Treat Behavior Problems in Dogs (trazodone dosing and indications) (2024)
  2. Foss T. Trazodone in Veterinary Medicine — Today's Veterinary Nurse (mechanism, off-label status, adverse effects, serotonin syndrome) (2017)
  3. Trazodone for Dogs & Cats — Clinician's Brief (SARI class, receptor mechanism, situational dosing timing, onset) (2018)
  4. Gruen ME, Roe SC, Griffith E, Hamilton A, Sherman BL. Use of trazodone to facilitate postsurgical confinement in dogs. JAVMA 245(3):296–301 (2014)
  5. Gruen ME, Sherman BL. Use of trazodone as an adjunctive agent in the treatment of canine anxiety disorders: 56 cases (1995–2007). JAVMA 233(12):1902–1907 (2008)

More clinical updates

CanineJun 5, 2026

Tasipimidine (Tessie) for Noise Aversion and Separation Anxiety in Dogs

First FDA-approved drug for both noise aversion and separation anxiety in dogs. Alpha-2 agonist mechanism, oral solution, May 2026 approval.

Read →
FelineJun 6, 2026

Gabapentin for Pre-Visit Feline Anxiety: Evidence and Clinical Use

The evergreen clinical reference on gabapentin in cats: randomized and systematic-review evidence for pre-visit anxiolysis, the ~40% ataxia rate and 8-hour resolution window, cardiovascular safety, the pregabalin comparison, and the emerging atopic-dermatitis adjunct signal.

Read →
Dogs & CatsJul 12, 2026

Clomipramine (Clomicalm) for Dogs and Cats: Behavioral Dosing, Efficacy, and Safety

Clomipramine is a tricyclic antidepressant FDA-approved (Clomicalm) as an adjunct to behavior modification for canine separation anxiety, and used off-label for feline urine marking and canine/feline compulsive disorders. This hub covers species-specific dosing, the registration and compulsive-disorder RCTs, adverse effects, MAOI/serotonergic interactions, and where it sits versus fluoxetine, trazodone, and buspirone.

Read →
CanineJul 13, 2026

Sileo (Dexmedetomidine Oromucosal Gel) for Canine Noise Aversion: Dosing, Efficacy, and Safety

Sileo (dexmedetomidine oromucosal gel) is the first and only FDA-approved treatment for canine noise aversion — an alpha-2 agonist absorbed transmucosally, dosed by weight as syringe "dots" and given shortly before or at the onset of an anticipated noise event. This hub covers label dosing, the pivotal RCT, adverse effects, contraindications, and where it sits against trazodone, clonidine, tasipimidine, and daily SSRIs.

Read →